Durvalumab-associated Late-onset Myocarditis Successfully Treated with Corticosteroid Therapy

We herein report a 66-year-old man with locally advanced non-small-cell lung cancer (NSCLC) who developed durvalumab-associated myocarditis. The patient underwent durvalumab administration every two weeks following concurrent chemoradiotherapy, without any adverse events or apparent disease progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Maetani, Tomoki, Hamaguchi, Toka, Nishimura, Takafumi, Marumo, Satoshi, Fukui, Motonari
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907760/
https://www.ncbi.nlm.nih.gov/pubmed/34433717
http://dx.doi.org/10.2169/internalmedicine.7644-21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8907760/
https://www.ncbi.nlm.nih.gov/pubmed/34433717
http://dx.doi.org/10.2169/internalmedicine.7644-21

Ejemplares similares